Contrarily, Choi et al. have reported a significantly higher BCR-free survival rate in pT2 prostate cancer patients with percent tumor volume ≤ 7.5%, which was assessed using histological samples (p < 0.001) [33]. Here, BCR is linked to neoplasm.